These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19222462)

  • 1. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
    Powell AM; Robson AM; Russell-Jones R; Barlow RJ
    Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod immunotherapy in the management of lentigo maligna.
    Powell AM; Russell-Jones R; Barlow RJ
    Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
    Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
    Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 5% imiquimod in the treatment of lentigo maligna.
    Wong JG; Toole JW; Demers AA; Musto G; Wiseman MC
    J Cutan Med Surg; 2012; 16(4):245-9. PubMed ID: 22784516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod.
    Ramsdell AM; Zeitouni N
    Dermatol Surg; 2009 Feb; 35(2):287-90. PubMed ID: 19215272
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
    Wolf IH; Cerroni L; Kodama K; Kerl H
    Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients.
    Van Meurs T; Van Doorn R; Kirtschig G
    Dermatol Surg; 2010 Jun; 36(6):853-8. PubMed ID: 20618370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Videodermatoscopy of lentigo maligna treated with imiquimod.
    Micali G; Lacarrubba F; Nardone B; Nasca MR
    J Drugs Dermatol; 2008 Nov; 7(11):1077-80. PubMed ID: 19110742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
    Kai AC; Richards T; Coleman A; Mallipeddi R; Barlow R; Craythorne EE
    Br J Dermatol; 2016 Jan; 174(1):165-8. PubMed ID: 26595446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical imiquimod therapy for lentigo maligna.
    Mahoney MH; Joseph MG; Temple C
    Ann Plast Surg; 2008 Oct; 61(4):419-24. PubMed ID: 18812714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
    Woodmansee CS; McCall MW
    Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of lentigo maligna with imiquimod before staged excision.
    Cotter MA; McKenna JK; Bowen GM
    Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lentigo maligna treated with 5% imiquimod cream].
    Martín T; Ojeda A; Martínez S; Vera A
    Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of extensive lentigo maligna after treatment with imiquimod.
    Piazza CD; Sampaio SA
    An Bras Dermatol; 2009; 84(1):82-4. PubMed ID: 19377765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod in the treatment of lentigo maligna.
    Rajpar SF; Marsden JR
    Br J Dermatol; 2006 Oct; 155(4):653-6. PubMed ID: 16965411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream.
    Borucki U; Metze D
    Dermatology; 2003; 207(3):326-8. PubMed ID: 14571081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.